The application of cell-based label-free technology in drug discovery

Biotechnology Journal

Volumn 3, Issue 4, 2008, Pages 484-495

  Xi, Biao ^a   Yu, Naichen ^a   Wang, Xiaobo ^a   Xu, Xiao ^a   Abassi, Yama A ^a  

^a ACEA Biosciences   (United States)

Author keywords

Cell based; Drug discovery; Impedance; Kinetic; Label free

Indexed keywords

BIOASSAY; DRUG PRODUCTS; PHYSIOLOGY; PROTEINS;

BIOCHEMICAL ASSAYS; DRUG DISCOVERY; LABEL-FREE TECHNOLOGY;

BIOTECHNOLOGY;

6 (1,3 DIOXO 1H,3H BENZO[DE]ISOQUINOLIN 2 YL) N HYDROXYHEXANAMIDE; CELL PROTEIN; CELL SURFACE RECEPTOR; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; HISTONE DEACETYLASE INHIBITOR; LANTRUNCULIN A; MEMBRANE RECEPTOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RECEPTOR BLOCKING AGENT; SCLEROPROTEIN;

AUTOANALYZER; BIOSENSOR; BIOTECHNOLOGY; CELL ADHESION; CELL ASSAY; CELL FUNCTION; CELL INVASION; CELL KINETICS; CELL LABELING; CELL MEDIATED CYTOTOXICITY; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; DRUG DESIGN; DRUG RESEARCH; DRUG TARGETING; HUMAN; IMPEDANCE; NON INVASIVE MEASUREMENT; NONHUMAN; PHYSICAL CHEMISTRY; PIEZOELECTRICITY; PRIORITY JOURNAL; PROCESS TECHNOLOGY; PROTEIN EXPRESSION; REFRACTION INDEX; REVIEW; SIGNAL NOISE RATIO; SIGNAL TRANSDUCTION;

EID: 42949124474     PISSN: 18606768     EISSN: None     Source Type: Journal    
DOI: 10.1002/biot.200800020     Document Type: Review

References (66)

1. 1 Kola, I., Landis, J., Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 2004, 3, 711–715.
2. 2 Horrobin, D. F., Modern biomedical research: an internally self‐consistent universe with little contact with medical reality? Nat. Rev. Drug Discov. 2003, 2, 151–154.
3. 3 Drews, J., Strategic trends in the drug industry. Drug Discov. Today 2003, 8, 411–420.
4. 4 Cooper, M. A., Non‐optical screening platforms: the next wave in label‐free screening? Drug Discov. Today 2006, 11, 1068–1074.
5. 5 Cooper, M. A., Optical biosensors: where next and how soon? Drug Discov. Today 2006, 11, 1061–1067.
6. 6 McGuinness, R., Impedance‐based cellular assay technologies: recent advances, future promise. Curr. Opin. Pharmacol. 2007, 7, 535–540.
7. 7 Verdonk, E., Johnson, K., McGuinness, R., Leung, G. et al., Cellular dielectric spectroscopy: a label‐free comprehensive platform for functional evaluation of endogenous receptors. Assay Drug Dev. Technol. 2006, 4, 609–619.
8. 8 Atienza, J. M., Yu, N., Wang, X., Xu, X. et al., Label‐free and real‐time cell‐based kinase assay for screening selective and potent receptor tyrosine kinase inhibitors using microelectronic sensor array. J. Biomol. Screen. 2006, 11, 634–643.
9. 9 Fang, Y., Label‐free cell‐based assays with optical biosensors in drug discovery. Assay Drug Dev. Technol. 2006, 4, 583–595.
10. 10 Hug, T. S., Biophysical methods for monitoring cell‐substrate interactions in drug discovery. Assay Drug Dev. Technol. 2003, 1, 479–488.
11. 11 Denholm, E. M., Stankus, G. P., Differential effects of two fluorescent probes on macrophage migration as assessed by manual and automated methods. Cytometry 1995, 19, 366–369.
12. 12 Abbitt, K. B., Rainger, G. E., Nash, G. B., Effects of fluorescent dyes on selectin and integrin‐mediated stages of adhesion and migration of flowing leukocytes. J. Immunol. Methods 2000 239, 109–119.
13. 13 Giaever, I., Keese, C. R., A morphological biosensor for mammalian cells. Nature 1993, 366, 591–592.
14. 14 Solly, K., Wang, X., Xu, X., Strulovici, B. et al., Application of real‐time cell electronic sensing (RT‐CES) technology to cell‐based assays. Assay Drug Dev. Technol. 2004, 2, 363–372.
15. 15 Atienza, J. M., Yu, N., Kirstein, S. L., Xi, B. et al., Dynamic and label‐free cell‐based assays using the real‐time cell electronic sensing system. Assay Drug Dev. Technol. 2006, 4, 597–607.
16. 16 Giaever, I., Keese, C. R., Monitoring fibroblast behavior in tissue culture with an applied electric field. Proc. Natl. Acad. Sci. USA 1984, 81, 3761–3764.
17. 17 Giaever, I., Keese, C. R., Use of electric fields to monitor the dynamical aspect of cell behavior in tissue culture. IEEE Trans. Biomed. Eng. 1986, 33, 242–247.
18. 18 Thedinga, E., Kob, A., Holst, H., Keuer, A. et al., Online monitoring of cell metabolism for studying pharmacodynamic effects. Toxicol. Appl. Pharmacol. 2007, 220, 33–44.
19. 19 Fang, Y., Li, G. G., Peng, J., Optical biosensor provides insights for bradykinin B(2) receptor signaling in A431 cells. FEBS Lett. 2005, 579, 6365–6374.
20. 20 Fang, Y., Ferrie, A. M., Fontaine, N. H., Yuen, P. K., Characteristics of dynamic mass redistribution of epidermal growth factor receptor signaling in living cells measured with label‐free optical biosensors. Anal. Chem. 2005, 77, 5720–5725.
21. 21 Cunningham, B. T., Li, P., Schulz, S., Lin, B. et al., Label‐free assays on the BIND system. J. Biomol. Screen. 2004, 9, 481–490.
22. 22 Hug, T. S., Prenosil, J. E., Maier, P., Morbidelli, M., Optical waveguide lightmode spectroscopy (OWLS) to monitor cell proliferation quantitatively. Biotechnol. Bioeng. 2002, 80, 213–221.
23. 23 Hug, T. S., Prenosil, J. E., Morbidelli, M., Optical waveguide lightmode spectroscopy as a new method to study adhesion of anchorage‐dependent cells as an indicator of metabolic state. Biosens. Bioelectron. 2001, 16, 865–874.
24. 24 Hug, T. S., Prenosil, J. E., Maier, P., Morbidelli, M., On‐line monitoring of adhesion and proliferation of cultured hepatoma cells using optical waveguide lightmode spectroscopy (OWLS). Biotechnol. Prog. 2002, 18, 1408–1413.
25. 25 Voros, J., Graf, R., Kenausis, G. L., Mayer, J. et al., Feasibility study of an online toxicological sensor based on the optical waveguide technique. Biosens. Bioelectron. 2000, 15, 423–429.
26. 26 Marx, K. A., Zhou, T., Montrone, A., Schulze, H. et al., A quartz crystal microbalance cell biosensor: detection of microtubule alterations in living cells at nM nocodazole concentrations. Biosens. Bioelectron. 2001, 16, 773–782.
27. 27 Marx, K. A., Zhou, T., Warren, M., Braunhut, S. J., Quartz crystal microbalance study of endothelial cell number dependent differences in initial adhesion and steady‐state behavior: evidence for cell‐cell cooperativity in initial adhesion and spreading. Biotechnol. Prog. 2003, 19, 987–999.
28. 28 Marx, K. A., Zhou, T., Montrone, A., McIntosh, D. et al., Quartz crystal microbalance biosensor study of endothelial cells and their extracellular matrix following cell removal: Evidence for transient cellular stress and viscoelastic changes during detachment and the elastic behavior of the pure matrix. Anal. Biochem. 2005, 343, 23–34.
29. 29 Marx, K. A., Zhou, T., Montrone, A., McIntosh, D. et al., A comparative study of the cytoskeleton binding drugs nocodazole and taxol with a mammalian cell quartz crystal microbalance biosensor: different dynamic responses and energy dissipation effects. Anal. Biochem. 2007, 361, 77–92.
30. 30 Zhou, T., Marx, K. A., Warren, M., Schulze, H. et al., The quartz crystal microbalance as a continuous monitoring tool for the study of endothelial cell surface attachment and growth. Biotechnol. Prog. 2000, 16, 268–277.
31. 31 Wu, M., Neilson, A., Swift, A. L., Tamagnine, J. et al., Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am. J. Physiol. Cell Physiol. 2007, 292, C125–136.
32. 32 Sridharan, V., Guichard, J., Bailey, R. M., Kasiganesan, H. et al., The prolyl hydroxylase oxygen‐sensing pathway is cytoprotective and allows maintenance of mitochondrial membrane potential during metabolic inhibition. Am. J. Physiol. Cell Physiol. 2007, 292, C719–728.
33. 33 Crunkhorn, S., Dearie, F., Mantzoros, C., Gami, H. et al., Peroxisome proliferator activator receptor gamma coactivator‐1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen‐activated protein kinase activation. J. Biol. Chem. 2007, 282, 15439–15450.
34. 34 Disanza, A., Steffen, A., Hertzog, M., Frittoli, E. et al., Actin polymerization machinery: the finish line of signaling networks, the starting point of cellular movement. Cell. Mol. Life Sci. 2005, 62, 955–970.
35. 35 Juliano, R. L., Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin‐superfamily members. Annu. Rev. Pharmacol. Toxicol. 2002, 42, 283–323.
36. 36 Calderwood, D. A., Shattil, S. J., Ginsberg, M. H., Integrins and actin filaments: reciprocal regulation of cell adhesion and signaling. J. Biol. Chem. 2000, 275, 22607–22610.
37. 37 Nambi, P., Aiyar, N., G protein‐coupled receptors in drug discovery. Assay Drug Dev. Technol. 2003, 1, 305–310.
38. 38 Perez, D. M., Karnik, S. S., Multiple signaling states of Gprotein‐coupled receptors. Pharmacol. Rev. 2005, 57, 147–161.
39. 39 Howe, A. K., Juliano, R. L., Regulation of anchorage‐dependent signal transduction by protein kinase A and p21‐activated kinase. Nat. Cell. Biol. 2000, 2, 593–600.
40. 40 Garcia, L. J., Rosado, J. A., Gonzalez, A., Jensen, R. T., Cholecystokinin‐stimulated tyrosine phosphorylation of p125FAK and paxillin is mediated by phospholipase C‐dependent and ‐independent mechanisms and requires the integrity of the actin cytoskeleton and participation of p21rho. Biochem. J. 1997, 327, 461–472.
41. 41 Rosado, J. A., Salido, G. M., Garcia, L. J., Activation of m3 muscarinic receptors induces rapid tyrosine phosphorylation of p125(FAK), p130(cas), and paxillin in rat pancreatic acini. Arch. Biochem. Biophys. 2000, 377, 85–94.
42. 42 Zhang, Z., Neff, L., Bothwell, A. L., Baron, R. et al., Calcitonin induces dephosphorylation of Pyk2 and phosphorylation of focal adhesion kinase in osteoclasts. Bone 2002, 31, 359–365.
43. 43 Zhang, Z., Baron, R., Horne, W. C., Integrin engagement, the actin cytoskeleton, and c‐Src are required for the calcitonin‐induced tyrosine phosphorylation of paxillin and HEF1, but not for calcitonin‐induced Erk1/2 phosphorylation. J. Biol. Chem. 2000, 275, 37219–37223.
44. 44 Zhang, Z., Hernandez‐Lagunas, L., Horne, W. C., Baron, R., Cytoskeleton‐dependent tyrosine phosphorylation of the p130(Cas) family member HEF1 downstream of the G protein‐ coupled calcitonin receptor. Calcitonin induces the association of HEF1, paxillin, and focal adhesion kinase. J. Biol. Chem. 1999, 274, 25093–25098.
45. 45 Yu, N., Atienza, J. M., Bernard, J., Blanc, S. et al., Real‐time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein‐coupled receptors. Anal. Chem. 2006, 78, 35–43.
46. 46 Coleman, M. L., Olson, M. F., Rho GTPase signalling pathways in the morphological changes associated with apoptosis. Cell Death Differ. 2002, 9, 493–504.
47. 47 Coleman, M. L., Sahai, E. A., Yeo, M., Bosch, M. et al., Membrane blebbing during apoptosis results from caspase‐mediated activation of ROCK I. Nat. Cell Biol. 2001, 3, 339–345.
48. 48 Arndt, S., Seebach, J., Psathaki, K., Galla, H. et al., Bioelectrical impedance assay to monitor changes in cell shape during apoptosis. Biosens. Bioelectron. 2004, 19, 583–594.
49. 49 Xing, J. Z., Zhu, L., Gabos, S., Xie, L., Microelectronic cell sensor assay for detection of cytotoxicity and prediction of acute toxicity. Toxicol. In Vitro 2006, 20, 995–1004.
50. 50 Xing, J. Z., Zhu, L., Jackson, J. A., Gabos, S. et al., Dynamic monitoring of cytotoxicity on microelectronic sensors. Chem. Res. Toxicol. 2005, 18, 154–161.
51. 51 Heidel, J. D., Liu, J. Y., Yen, Y., Zhou, B. et al., Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivo. Clin. Cancer Res. 2007, 13, 2207–2215.
52. 52 Lanier, L. L., NK cell recognition. Annu. Rev. Immunol. 2005, 23, 225–274.
53. 53 Cerwenka, A., Lanier, L. L., Ligands for natural killer cell receptors: redundancy or specificity. Immunol. Rev. 2001, 181, 158–169.
54. 54 Smyth, M. J., Cretney, E., Kelly, J. M., Westwood, J. A. et al., Activation of NK cell cytotoxicity. Mol. Immunol. 2005, 42, 501–510.
55. 55 Trapani, J. A., Sutton, V. R., Granzyme B: pro‐apoptotic, antiviral and antitumor functions. Curr. Opin. Immunol. 2003, 15, 533–543.
56. 56 Glamann, J., Hansen, A. J., Dynamic detection of natural killer cell‐mediated cytotoxicity and cell adhesion by electrical impedance measurements. Assay Drug Dev. Technol. 2006, 4, 555–563.
57. 57 Hynes, R. O., Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110, 673–687.
58. 58 Stupack, D. G., Cheresh, D. A., Get a ligand, get a life: integrins, signaling and cell survival. J. Cell Sci. 2002, 115, 3729–3738.
59. 59 Mousa, S. A., Anti‐integrin as novel drug‐discovery targets: potential therapeutic and diagnostic implications. Curr. Opin. Chem. Biol. 2002, 6, 534–541.
60. 60 Wegener, J., Keese, C. R., Giaever, I., Electric cell‐substrate impedance sensing (ECIS) as a noninvasive means to monitor the kinetics of cell spreading to artificial surfaces. Exp. Cell Res. 2000, 259, 158–166.
61. 61 Xiao, C., Lachance, B., Sunahara, G., Luong, J. H., An indepth analysis of electric cell‐substrate impedance sensing to study the attachment and spreading of mammalian cells. Anal. Chem. 2002, 74, 1333–1339.
62. 62 Atienza, J. M., Zhu, J., Wang, X., Xu, X. et al., Dynamic monitoring of cell adhesion and spreading on microelectronic sensor arrays. J. Biomol. Screen. 2005, 10, 795–805.
63. 63 Lauffenburger, D. A., Horwitz, A. F., Cell migration: a physically integrated molecular process. Cell 1996, 84, 359–369.
64. 64 Webb, D. J., Parsons, J. T., Horwitz, A. F., Adhesion assembly, disassembly and turnover in migrating cells–over and over and over again. Nat. Cell Biol. 2002, 4, E97–100.
65. 65 Keese, C. R., Wegener, J., Walker, S. R., Giaever, I., Electrical wound‐healing assay for cells in vitro. Proc. Natl. Acad. Sci. USA 2004, 101, 1554–1559.
66. 66 Kirstein, S. L., Atienza, J. M., Xi, B., Zhu, J. et al., Live cell quality control and utility of real‐time cell electronic sensing for assay development. Assay Drug Dev. Technol. 2006, 4, 545–553.